ALBI (Albumin-Bilirubin) Grade for Hepatocellular Carcinoma (HCC)

ورودی‌های بالینی بیمار

حداقل ۱ — حداکثر ۶ • واحد: g/L

حداقل ۳ — حداکثر ۵۰۰ • واحد: μmol/L

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
albi score
—score
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Grade 1-10–-2.6
  • Grade 2-2.6–-1.39
  • Grade 3-1.39–10
Direct Clinical Answer

The ALBI (Albumin-Bilirubin) Grade for Hepatocellular Carcinoma (HCC) calculates predicting survival in hepatocellular carcinoma patients based on serum albumin and bilirubin concentrations. Key inputs include albumin. Scores guide managing portal hypertension complications, referring for liver transplant evaluation, and supportive care. Routine clinical application promotes standardized evidence-based patient management.

Clinical Guidelines & Evidence

Predicts survival in hepatocellular carcinoma patients based on serum albumin and bilirubin concentrations

Clinical Indication

The ALBI (Albumin-Bilirubin) Grade for Hepatocellular Carcinoma (HCC) is indicated for bedside clinical practice to support Predicts survival in hepatocellular carcinoma patients based on serum albumin and bilirubin concentrations. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients with decompensated liver cirrhosis, acute liver failure, portal hypertension, ascites, or end-stage liver disease awaiting organ allocation. Clinical application is indicated across Hepatology clinics, liver transplant assessment centers, gastroenterology wards, and liver ICUs.

Limitations & Contraindications

Due to muscle wasting and reduced hepatic creatine synthesis, serum creatinine routinely underestimates renal dysfunction in cirrhosis.

Clinical Pearls & Action Plan

Preventing spontaneous bacterial peritonitis (SBP), managing variceal hemorrhage, and monitoring hepatic encephalopathy are top clinical priorities.

Formula & Variables:

ALBI = (log10 bilirubin × 0.66) + (albumin × -0.085), where bilirubin is in μmol/L and albumin in g/L

Input Parameters

NameTypeRequiredDescription
albuminfloatYesSerum albumin concentration(g/L)
bilirubinfloatYesSerum bilirubin concentration(μmol/L)

Score Interpretation & Guidance

RangeStageDescription
-10–-2.6Grade 1Best prognosis
-2.6–-1.39Grade 2Intermediate prognosis
-1.39–10Grade 3Poorest prognosis

Evidence-Based References (EBM)

  • Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33(6):550-8. doi: 10.1200/JCO.2014.57.9151.DOI: 10.1200/JCO.2014.57.9151
  • Hiraoka A, Michitaka K, Kumada T, et al. Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function. Liver Cancer. 2017;6(4):325-336. doi: 10.1159/000479984.DOI: 10.1159/000479984
  • Chen B, Lin S. Albumin-bilirubin (ALBI) score at admission predicts possible outcomes in patients with acute-on-chronic liver failure. Medicine (Baltimore). 2017;96(24):e7142. doi: 10.1097/MD.0000000000007142.DOI: 10.1097/MD.0000000000007142

Related calculators